Carcinoma, Mucoepidermoid - 25 Studies Found
Completed |
: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors :
|
Completed |
: Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer :
|
Completed |
: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu :
|
Active, not recruiting |
: Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors :
|
Completed |
: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers :
|
Completed |
: Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer :
|
Completed |
: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer :
|
Completed |
: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) :
|
Completed |
: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction :
|
Recruiting |
: Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy :
|